The company has not filed an annual or quarterly report since its FY2016 20-F, filed Mar 16, 2017. Its latest SEC filing is a SC 13G/A from Feb 13, 2018.
20-F for FY2016, filed Mar 16, 2017
The sections below describe the company as of the FY2016 annual report.
Develops and sells lipid-based nutrition ingredients to infant-formula and supplement manufacturers, plus branded medical foods for physician-supervised patients.
20-F for FY2016, filed Mar 16, 2017
Nutrition ingredients go to branded-product manufacturers, including infant-formula makers, and to supplement and food companies, with sales through AL, distributors and local sales offices. VAYA products are marketed directly to physicians in the United States, Singapore and Hong Kong, and reach buyers through pharmaceutical wholesalers, the online pharmacy and physician channels; partners handle distribution elsewhere.
20-F for FY2016, filed Mar 16, 2017We sell our nutrition products to manufacturers of branded products in different markets around the world. Those manufacturers then…View ↗
Sales and distribution of the InFat product are carried out by AL. In most of our markets sales are conducted directly by AL. See “— Joint…View ↗
We sell our krill, PS and GPC products to companies that manufacture and market dietary supplements, to food companies that combine our…View ↗
In the United States, which accounted for the vast majority of our VAYA Pharma sales in 2016, the marketing and sales of these products are…View ↗
Outside the United States, marketing and distribution of the VAYA Pharma products is carried out either by license partners or directly by…View ↗
We sell our nutrition products to manufacturers of branded products in different markets around the world. For example, we have developed…View ↗
Competes with IOI Loders Croklaan, Aker BioMarine, Neptune Technologies & Bioresources, Rimfrost USA, Chemi Nutraceuticals, Lipoid, Lipogen, GlaxoSmithKline, AbbVie, Amarin, Eli Lilly, Shire, Abbott Laboratories, Nestlé, and Danone
20-F for FY2016, filed Mar 16, 2017With respect to the InFat product, we currently compete with one other company offering an sn-2 palmitate product, IOI Loders Croklaan, a…View ↗
Loading...
